A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function
- PMID: 19219043
- PMCID: PMC4509508
- DOI: 10.1038/ng.317
A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function
Erratum in
- Nat Genet. 2010 May;42(5):464
Retraction in
-
Retraction: A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function.Nat Genet. 2016 Feb;48(2):221. doi: 10.1038/ng0216-221. Nat Genet. 2016. PMID: 26813765 Free PMC article. No abstract available.
Abstract
microRNAs (miRNAs) are small noncoding RNAs that regulate gene expression by targeting messenger RNA (mRNA) transcripts. Recently, a miRNA expression profile of human tumors has been characterized by an overall miRNA downregulation. Explanations for this observation include a failure of miRNA post-transcriptional regulation, transcriptional silencing associated with hypermethylation of CpG island promoters and miRNA transcriptional repression by oncogenic factors. Another possibility is that the enzymes and cofactors involved in miRNA processing pathways may themselves be targets of genetic disruption, further enhancing cellular transformation. However, no loss-of-function genetic alterations in the genes encoding these proteins have been reported. Here we have identified truncating mutations in TARBP2 (TAR RNA-binding protein 2), encoding an integral component of a DICER1-containing complex, in sporadic and hereditary carcinomas with microsatellite instability. The presence of TARBP2 frameshift mutations causes diminished TRBP protein expression and a defect in the processing of miRNAs. The reintroduction of TRBP in the deficient cells restores the efficient production of miRNAs and inhibits tumor growth. Most important, the TRBP impairment is associated with a destabilization of the DICER1 protein. These results provide, for a subset of human tumors, an explanation for the observed defects in the expression of mature miRNAs.
Figures
Comment in
-
Reassessing the TARBP2 mutation rate in hereditary nonpolyposis colorectal cancer.Nat Genet. 2010 Oct;42(10):817-8; author reply 818. doi: 10.1038/ng1010-817. Nat Genet. 2010. PMID: 20877318 No abstract available.
References
-
- Lu J, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–838. - PubMed
-
- Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat. Rev. Cancer. 2006;6:857–866. - PubMed
-
- Gaur A, et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res. 2007;67:2456–2468. - PubMed
-
- Saito Y, et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell. 2006;9:435–443. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
